<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Atiq F</submitter><funding>Science Foundation Ireland</funding><funding>NHLBI NIH HHS</funding><funding>ZonMw</funding><funding>NIH</funding><pagination>2752-2760</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11533894</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>22(10)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>von Willebrand factor (VWF)-R1205H variant (Vicenza) results in markedly enhanced VWF clearance in humans that has been shown to be largely macrophage-mediated. However, the biological mechanisms underlying this enhanced clearance remain poorly understood.&lt;h4>Objectives&lt;/h4>This study aimed to investigate the roles of (i) specific VWF domains and (ii) different macrophage receptors in regulating enhanced VWF-R1205H clearance.&lt;h4>Methods&lt;/h4>In vivo clearance of full-length and truncated wild-type (WT)-VWF and VWF with R1205 substitutions was investigated in VWF&lt;sup>-/-&lt;/sup> mice. Plate-binding assays were employed to characterize VWF binding to purified scavenger receptor class A member 1 (SR-AI), low-density lipoprotein receptor-related protein-1 (LRP1) cluster II or cluster IV receptors, and macrophage galactose-type lectin.&lt;h4>Results&lt;/h4>In full-length VWF missing the A1 domain, introduction of R1205H led to significantly enhanced clearance in VWF&lt;sup>-/-&lt;/sup> mice compared with WT-VWF missing the A1 domain. Importantly, R1205H in a truncated VWF-D'D3 fragment also triggered increased clearance compared with WT-VWF-D'D3. Additional in vivo studies demonstrated that VWF-R1205K (which preserves the positive charge at 1205) exhibited normal clearance, whereas VWF-R1205E (which results in loss of the positive charge) caused significantly enhanced clearance, pinpointing the importance of the positive charge at VWF-R1205. In vitro plate-binding studies confirmed increased VWF-R1205H interaction with SR-AI compared with WT-VWF. Furthermore, significantly enhanced VWF-R1205H binding to LRP1 cluster IV (P &lt; .001) and less marked enhanced binding to LRP1 cluster II (P = .034) was observed. In contrast, VWF-R1205H and WT-VWF demonstrated no difference in binding affinity to macrophage galactose-type lectin.&lt;h4>Conclusion&lt;/h4>Disruption of the positive charge at amino acid R1205 causes conformational changes in the VWF-D'D3 domains and triggers enhanced LRP1-mediated and SR-AI-mediated clearance.</pubmed_abstract><journal>Journal of thrombosis and haemostasis : JTH</journal><pubmed_title>R1205H (Vicenza) causes conformational changes in the von Willebrand factor D'D3 domains and enhances von Willebrand factor binding to clearance receptors LRP1 and SR-AI.</pubmed_title><pmcid>PMC11533894</pmcid><funding_grant_id>P01 HL144457</funding_grant_id><funding_grant_id>P01 HL081588</funding_grant_id><pubmed_authors>Baci B</pubmed_authors><pubmed_authors>Aburawi HE</pubmed_authors><pubmed_authors>O'Donnell JS</pubmed_authors><pubmed_authors>Rawley O</pubmed_authors><pubmed_authors>O'Sullivan JM</pubmed_authors><pubmed_authors>Amin A</pubmed_authors><pubmed_authors>Chion A</pubmed_authors><pubmed_authors>Cooke N</pubmed_authors><pubmed_authors>Terraube V</pubmed_authors><pubmed_authors>Ozbil M</pubmed_authors><pubmed_authors>Byrne C</pubmed_authors><pubmed_authors>Lillicrap D</pubmed_authors><pubmed_authors>Hulshof AM</pubmed_authors><pubmed_authors>Doherty D</pubmed_authors><pubmed_authors>Atiq F</pubmed_authors></additional><is_claimable>false</is_claimable><name>R1205H (Vicenza) causes conformational changes in the von Willebrand factor D'D3 domains and enhances von Willebrand factor binding to clearance receptors LRP1 and SR-AI.</name><description>&lt;h4>Background&lt;/h4>von Willebrand factor (VWF)-R1205H variant (Vicenza) results in markedly enhanced VWF clearance in humans that has been shown to be largely macrophage-mediated. However, the biological mechanisms underlying this enhanced clearance remain poorly understood.&lt;h4>Objectives&lt;/h4>This study aimed to investigate the roles of (i) specific VWF domains and (ii) different macrophage receptors in regulating enhanced VWF-R1205H clearance.&lt;h4>Methods&lt;/h4>In vivo clearance of full-length and truncated wild-type (WT)-VWF and VWF with R1205 substitutions was investigated in VWF&lt;sup>-/-&lt;/sup> mice. Plate-binding assays were employed to characterize VWF binding to purified scavenger receptor class A member 1 (SR-AI), low-density lipoprotein receptor-related protein-1 (LRP1) cluster II or cluster IV receptors, and macrophage galactose-type lectin.&lt;h4>Results&lt;/h4>In full-length VWF missing the A1 domain, introduction of R1205H led to significantly enhanced clearance in VWF&lt;sup>-/-&lt;/sup> mice compared with WT-VWF missing the A1 domain. Importantly, R1205H in a truncated VWF-D'D3 fragment also triggered increased clearance compared with WT-VWF-D'D3. Additional in vivo studies demonstrated that VWF-R1205K (which preserves the positive charge at 1205) exhibited normal clearance, whereas VWF-R1205E (which results in loss of the positive charge) caused significantly enhanced clearance, pinpointing the importance of the positive charge at VWF-R1205. In vitro plate-binding studies confirmed increased VWF-R1205H interaction with SR-AI compared with WT-VWF. Furthermore, significantly enhanced VWF-R1205H binding to LRP1 cluster IV (P &lt; .001) and less marked enhanced binding to LRP1 cluster II (P = .034) was observed. In contrast, VWF-R1205H and WT-VWF demonstrated no difference in binding affinity to macrophage galactose-type lectin.&lt;h4>Conclusion&lt;/h4>Disruption of the positive charge at amino acid R1205 causes conformational changes in the VWF-D'D3 domains and triggers enhanced LRP1-mediated and SR-AI-mediated clearance.</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Oct</publication><modification>2026-06-04T00:12:59.147Z</modification><creation>2026-05-03T03:12:11.547Z</creation></dates><accession>S-EPMC11533894</accession><cross_references><pubmed>38996914</pubmed><doi>10.1016/j.jtha.2024.06.023</doi></cross_references></HashMap>